Skip to main content

Table Ivermectin treatment coverage of the eligible population (1995–1999) and LF antigenemia (1999) among male residents in five ivermectin treated villages, with 1999 LF antigenemia in one untreated village (Gwamlar)

From: Mass ivermectin treatment for Onchocerciasis: Lack of evidence for collateral impact on transmission of Wuchereria bancroftiin areas of co-endemicity

Village Angwan Lemu Apanda Bakin-Kogi Lankan Mungkohot Gwamlar
Ivermectin rounds 2 2 2 5 5 -
Mean coverage (range) 91.4% (91–92) 66.9% (58–76) 85.3% (82–89) 85.9% (65–95) 77% (73–80) -
1999 coverage 92% 58% 89% 90% 80% -
% LF antigenemia in males (n) 40% (30) 43% (30) 27% (30) 47% (30) 47% (30) 58% (50)